TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,649,000 | +944.6% | 492,661 | +476.2% | 0.00% | – |
| Q2 2021 | $828,000 | -39.9% | 85,498 | -33.5% | 0.00% | – |
| Q1 2021 | $1,377,000 | -61.5% | 128,543 | -47.1% | 0.00% | -100.0% |
| Q4 2020 | $3,572,000 | -26.0% | 242,819 | -28.6% | 0.00% | -33.3% |
| Q3 2020 | $4,828,000 | +1279.4% | 340,187 | +685.7% | 0.00% | – |
| Q2 2020 | $350,000 | +104.7% | 43,300 | -0.2% | 0.00% | – |
| Q1 2020 | $171,000 | +489.7% | 43,405 | +51.8% | 0.00% | – |
| Q4 2019 | $29,000 | +107.1% | 28,588 | +27.1% | 0.00% | – |
| Q1 2019 | $14,000 | -67.4% | 22,494 | -8.8% | 0.00% | – |
| Q4 2018 | $43,000 | -60.6% | 24,662 | +28.2% | 0.00% | – |
| Q4 2016 | $109,000 | – | 19,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |